{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:47:13Z","timestamp":1792673233070,"version":"4.5.0"},"reference-count":142,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"vor","delay-in-days":3520,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s13311-013-0230-5","type":"journal-article","created":{"date-parts":[[2013,10,18]],"date-time":"2013-10-18T09:19:51Z","timestamp":1382087991000},"page":"128-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["The Treatment of Tremor"],"prefix":"10.1016","volume":"11","author":[{"given":"Susanne A.","family":"Schneider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnther","family":"Deuschl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-013-0230-5_bib1","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/mds.22838","article-title":"How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor","volume":"25","author":"Louis","year":"2010","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0230-5_bib2","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/mds.20884","article-title":"Quality of life and personality in essential tremor patients","volume":"21","author":"Lorenz","year":"2006","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0230-5_bib3","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.parkreldis.2005.05.009","article-title":"Quality of life in Essential Tremor Questionnaire (QUEST): development and initial validation","volume":"11","author":"Troster","year":"2005","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1007\/s13311-013-0230-5_bib4","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/j.1468-1331.2010.03295.x","article-title":"The psychosocial burden of essential tremor in an outpatient- and a community-based cohort","volume":"18","author":"Lorenz","year":"2011","journal-title":"Eur J Neurol"},{"key":"10.1007\/s13311-013-0230-5_bib5","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/mds.870130508","article-title":"Clinical characteristics of essential tremor: data from a community- based study","volume":"13","author":"Louis","year":"1998","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0230-5_bib6","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1002\/mds.22755","article-title":"Essential tremor \u2013 Neurodegenerative or nondegenerative disease towards a working definition of ET","volume":"24","author":"Deuschl","year":"2009","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0230-5_bib7","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.ncl.2009.04.003","article-title":"Tremor: clinical features, pathophysiology, and treatment","volume":"27","author":"Elble","year":"2009","journal-title":"Neurol Clin"},{"key":"10.1007\/s13311-013-0230-5_bib8","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1212\/WNL.0b013e318236f0fd","article-title":"Evidence-based guideline update: Treatment of essential tremor: Report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"77","author":"Zesiewicz","year":"2011","journal-title":"Neurology"},{"key":"10.1007\/s13311-013-0230-5_bib9","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S1474-4422(10)70322-7","article-title":"Treatment of patients with essential tremor","volume":"10","author":"Deuschl","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-013-0230-5_bib10","first-page":"48","article-title":"Defining dystonic tremor","volume":"11","author":"Elble","year":"2013","journal-title":"Curr Neuropharmacol"},{"key":"10.1007\/s13311-013-0230-5_bib11","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1002\/mds.21685","article-title":"Patients with adult-onset dystonic tremor resembling parkinsonian tremor have scans without evidence of dopaminergic deficit (SWEDDs)","volume":"22","author":"Schneider","year":"2007","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0230-5_bib12","series-title":"Parkinson's disease and movement disorders","first-page":"271","article-title":"Clinical rating scale for tremor","author":"Fahn","year":"1993"},{"key":"10.1007\/s13311-013-0230-5_bib13","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/mds.21412","article-title":"Assessment of interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor","volume":"22","author":"Stacy","year":"2007","journal-title":"Mov Disord"},{"issue":"Suppl.1","key":"10.1007\/s13311-013-0230-5_bib14","first-page":"S1","article-title":"The essential tremor rating assessment scale (TETRAS)","volume":"23","author":"Elble","year":"2008","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0230-5_bib15","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1093\/brain\/awl190","article-title":"Tremor amplitude is logarithmically related to 4- and 5-point tremor rating scales","volume":"129","author":"Elble","year":"2006","journal-title":"Brain"},{"key":"10.1007\/s13311-013-0230-5_bib16","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1002\/mds.23808","article-title":"Validation of digital spiral analysis as outcome parameter for clinical trials in essential tremor","volume":"26","author":"Haubenberger","year":"2011","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0230-5_bib17","first-page":"83","article-title":"Correlation of bowel symptoms with colonic transit, length, and faecal load in functional faecal retention","volume":"56","author":"Raahave","year":"2009","journal-title":"Dan Med Bull"},{"key":"10.1007\/s13311-013-0230-5_bib18","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3389\/fnhum.2012.00357","article-title":"Using a smart phone as a standalone platform for detection and monitoring of pathological tremors","volume":"6","author":"Daneault","year":"2013","journal-title":"Front Hum Neurosci"},{"key":"10.1007\/s13311-013-0230-5_bib19","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.parkreldis.2012.04.019","article-title":"Amplitude fluctuations in essential tremor","volume":"18","author":"Mostile","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1007\/s13311-013-0230-5_bib20","article-title":"Fragile x-associated tremor ataxia syndrome: the expanding clinical picture, pathophysiology, epidemiology, and update on treatment","volume":"2","author":"Hall","year":"2012","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"10.1007\/s13311-013-0230-5_bib21","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/jnnp.46.8.710","article-title":"Beta-adrenoreceptor mechanisms in essential tremor; a double-blind placebo controlled trial of metoprolol, sotalol and atenolol","volume":"46","author":"Leigh","year":"1983","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1007\/s13311-013-0230-5_bib22","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1136\/jnnp.42.10.904","article-title":"beta-Adrenoreceptor antagonists in essential tremor","volume":"42","author":"Jefferson","year":"1979","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1007\/s13311-013-0230-5_bib23","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1600-0404.1982.tb03141.x","article-title":"Atenolol vs. propranolol in essential tremor. A controlled, quantitative study","volume":"66","author":"Larsen","year":"1982","journal-title":"Acta Neurol Scand"},{"key":"10.1007\/s13311-013-0230-5_bib24","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/archneur.55.3.409","article-title":"Unrecognized Tourette syndrome in adult patients referred for psychogenic tremor","volume":"55","author":"Kulisevsky","year":"1998","journal-title":"Arch Neurol"},{"key":"10.1007\/s13311-013-0230-5_bib25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1053\/seiz.2001.0576","article-title":"Reversible valproate-induced choreiform movements","volume":"11","author":"Gunal","year":"2002","journal-title":"Seizure"},{"key":"10.1007\/s13311-013-0230-5_bib26","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1212\/WNL.38.2.241","article-title":"Efficacy of alprazolam for essential tremor","volume":"38","author":"Huber","year":"1988","journal-title":"Neurology"},{"key":"10.1007\/s13311-013-0230-5_bib27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00002826-198403000-00004","article-title":"A double-blind trial of clonazepam in benign essential tremor","volume":"7","author":"Thompson","year":"1984","journal-title":"Clin Neuropharmacol"},{"key":"10.1007\/s13311-013-0230-5_bib28","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/1531-8257(199905)14:3<468::AID-MDS1013>3.0.CO;2-M","article-title":"Acute and chronic effects of clozapine in essential tremor","volume":"14","author":"Ceravolo","year":"1999","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0230-5_bib29","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1212\/WNL.41.2_Part_1.311","article-title":"The effect of flunarizine on essential tremor","volume":"41","author":"Biary","year":"1991","journal-title":"Neurology"},{"key":"10.1007\/s13311-013-0230-5_bib30","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1212\/WNL.33.8.1076","article-title":"Nadolol in essential tremor","volume":"33","author":"Koller","year":"1983","journal-title":"Neurology"},{"key":"10.1007\/s13311-013-0230-5_bib31","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.neuroimage.2003.09.068","article-title":"Thalamic stimulation for parkinsonian tremor: correlation between regional cerebral blood flow and physiological tremor characteristics","volume":"21","author":"Fukuda","year":"2004","journal-title":"Neuroimage"},{"key":"10.1007\/s13311-013-0230-5_bib32","article-title":"Essential tremor","volume":"2007","author":"Ferreira","year":"2007","journal-title":"Clin Evid (Online)"},{"key":"10.1007\/s13311-013-0230-5_bib33","first-page":"66","article-title":"The control of essential tremor by propranolol","volume":"96","author":"Winkler","year":"1971","journal-title":"Trans Am Neurol Assoc"},{"key":"10.1007\/s13311-013-0230-5_bib34","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/ana.410130210","article-title":"Effect of a single oral dose of propranolol on essential tremor: a double-blind controlled study","volume":"13","author":"Calzetti","year":"1983","journal-title":"Ann Neuol"},{"key":"10.1007\/s13311-013-0230-5_bib35","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1212\/WNL.33.3.296","article-title":"Phenobarbital and propranolol in essential tremor: a double-blind controlled clinical trial","volume":"33","author":"Baruzzi","year":"1983","journal-title":"Neurology"},{"key":"10.1007\/s13311-013-0230-5_bib36","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ana.410240106","article-title":"Lack of association between essential tremor and Parkinson's disease","volume":"24","author":"Cleeves","year":"1988","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-013-0230-5_bib37","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1600-0404.1973.tb01280.x","article-title":"Treatment of benign essential tremor with propranolol. A controlled clinical trial","volume":"49","author":"Dupont","year":"1973","journal-title":"Acta Neurol Scand"},{"key":"10.1007\/s13311-013-0230-5_bib38","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1136\/jnnp.2008.148379","article-title":"Fragile X premutation presenting as essential tremor","volume":"79","author":"Gorman","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1007\/s13311-013-0230-5_bib39","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1056\/NEJM197405022901802","article-title":"Efficacy of chronic propranolol therapy in action tremors of the familial, senile or essential varieties","volume":"290","author":"Winkler","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1007\/s13311-013-0230-5_bib40","first-page":"892","article-title":"Long-term therapy of essential tremor with propranolol","volume":"115","author":"Murray","year":"1976","journal-title":"Can Med Assoc J"},{"key":"10.1007\/s13311-013-0230-5_bib41","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1212\/WNL.24.1.64","article-title":"Propranolol treatment of essential tremor","volume":"24","author":"Sweet","year":"1974","journal-title":"Neurology"},{"key":"10.1007\/s13311-013-0230-5_bib42","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1212\/WNL.25.11.1041","article-title":"Essential tremor: treatment with propranolol","volume":"25","author":"Tolosa","year":"1975","journal-title":"Neurology"},{"key":"10.1007\/s13311-013-0230-5_bib43","first-page":"247","article-title":"Beta 1 versus nonselective blockade in therapy of essential tremor","volume":"37","author":"Larsen","year":"1983","journal-title":"Adv Neurol"},{"key":"10.1007\/s13311-013-0230-5_bib44","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1136\/bmj.285.6342.608","article-title":"Double-blind controlled study of primidone in essential tremor: preliminary results","volume":"285","author":"Findley","year":"1982","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1007\/s13311-013-0230-5_bib45","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/jnnp.48.9.911","article-title":"Primidone in essential tremor of the hands and head: a double blind controlled clinical study","volume":"48","author":"Findley","year":"1985","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1007\/s13311-013-0230-5_bib46","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/j.1530-0277.2010.01197.x","article-title":"Transcallosal white matter degradation detected with quantitative fiber tracking in alcoholic men and women: selective relations to dissociable functions","volume":"34","author":"Pfefferbaum","year":"2010","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1007\/s13311-013-0230-5_bib47","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1093\/brain\/121.11.2127","article-title":"Time-frequency analysis of tremors","volume":"121","author":"O'Suilleabhain","year":"1998","journal-title":"Brain"},{"key":"10.1007\/s13311-013-0230-5_bib48","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1212\/WNL.39.12.1587","article-title":"Acute and chronic effects of propranolol and primidone in essential tremor","volume":"39","author":"Koller","year":"1989","journal-title":"Neurology"},{"key":"10.1007\/s13311-013-0230-5_bib49","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s11136-007-9224-2","article-title":"Two questionnaires for Parkinson's disease: are the PDQ-39 and PDQL equivalent?","volume":"16","author":"Martinez-Martin","year":"2007","journal-title":"Qual Life Res"},{"key":"10.1007\/s13311-013-0230-5_bib50","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1212\/01.wnl.0000200779.03748.0f","article-title":"Topiramate in essential tremor: a double-blind, placebo-controlled trial","volume":"66","author":"Ondo","year":"2006","journal-title":"Neurology"},{"key":"10.1007\/s13311-013-0230-5_bib51","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1212\/WNL.59.1.132","article-title":"A double-blind placebo-controlled trial of topiramate treatment for essential tremor","volume":"59","author":"Connor","year":"2002","journal-title":"Neurology"},{"key":"10.1007\/s13311-013-0230-5_bib52","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/00002826-200603000-00007","article-title":"A double-blind, placebo-controlled, crossover trial of topiramate in essential tremor","volume":"29","author":"Frima","year":"2006","journal-title":"Clin Neuropharmacol"},{"key":"10.1007\/s13311-013-0230-5_bib53","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/WNF.0b013e3180d09969","article-title":"Topiramate in essential tremor: findings from double-blind, placebo-controlled, crossover trials","volume":"31","author":"Connor","year":"2008","journal-title":"Clin Neuropharmacol"},{"key":"10.1007\/s13311-013-0230-5_bib54","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0022-510X(95)00128-O","article-title":"Efficacy of an adenosine antagonist, theophylline, in essential tremor: comparison with placebo and propranolol","volume":"132","author":"Mally","year":"1995","journal-title":"J Neurol Sci"},{"key":"10.1007\/s13311-013-0230-5_bib55","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1084\/jem.191.12.2031","article-title":"Expression of bcl-X(L) restores cell survival, but not proliferation off effector differentiation, in CD28-deficient T lymphocytes","volume":"191","author":"Dahl","year":"2000","journal-title":"J Exp Med"},{"key":"10.1007\/s13311-013-0230-5_bib56","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/mds.870130315","article-title":"Double-blind controlled trial of gabapentin in essential tremor","volume":"13","author":"Pahwa","year":"1998","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0230-5_bib57","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1001\/archneur.56.4.475","article-title":"A randomized placebo-controlled comparative trial of gabapentin and propranolol in essential tremor","volume":"56","author":"Gironell","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1007\/s13311-013-0230-5_bib58","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/mds.22418","article-title":"Zonisamide for essential tremor: an evaluator-blinded study","volume":"24","author":"Handforth","year":"2009","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0230-5_bib59","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.parkreldis.2004.09.004","article-title":"Effect of zonisamide on essential tremor: a pilot crossover study in comparison with arotinolol","volume":"11","author":"Morita","year":"2005","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1007\/s13311-013-0230-5_bib60","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/WNF.0b013e318074dd4f","article-title":"Zonisamide for essential tremor","volume":"30","author":"Ondo","year":"2007","journal-title":"Clin Neuropharmacol"},{"key":"10.1007\/s13311-013-0230-5_bib61","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/1531-8257(200101)16:1<89::AID-MDS1001>3.0.CO;2-L","article-title":"A teaching videotape for the assessment of essential tremor","volume":"16","author":"Louis","year":"2001","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0230-5_bib62","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/mds.20147","article-title":"Pilot efficacy and tolerability: a randomized, placebo-controlled trial of levetiracetam for essential tremor","volume":"19","author":"Handforth","year":"2004","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0230-5_bib63","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jns.2009.06.044","article-title":"Efficacy and tolerability of pregabalin in essential tremor: a randomized, double-blind, placebo-controlled, crossover trial","volume":"285","author":"Ferrara","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1007\/s13311-013-0230-5_bib64","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/mds.25264","article-title":"Multisite, double-blind, randomized, controlled study of pregabalin for essential tremor","volume":"28","author":"Zesiewicz","year":"2013","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0230-5_bib65","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1600-0404.1983.tb04833.x","article-title":"The effect of the GABA-agonist, progabide, on benign essential tremor. A controlled clinical trial","volume":"68","author":"Mondrup","year":"1983","journal-title":"Acta Neurol Scand"},{"key":"10.1007\/s13311-013-0230-5_bib66","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ana.410160517","article-title":"Amantadine in essential tremor","volume":"16","author":"Koller","year":"1984","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-013-0230-5_bib67","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00002826-198904000-00009","article-title":"Tradozone in essential tremor. Probe of serotoninergic mechanisms","volume":"12","author":"Koller","year":"1989","journal-title":"Clin Neuropharmacol"},{"key":"10.1007\/s13311-013-0230-5_bib68","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/mds.10371","article-title":"Mirtazapine in essential tremor: a double-blind, placebo-controlled pilot study","volume":"18","author":"Pahwa","year":"2003","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0230-5_bib69","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.clineuro.2005.01.002","article-title":"Olanzapine versus propranolol in essential tremor","volume":"108","author":"Yetimalar","year":"2005","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1007\/s13311-013-0230-5_bib70","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1212\/WNL.43.6.1159","article-title":"Identical twins with similar onset of Parkinson's disease: a case report","volume":"43","author":"Pahwa","year":"1993","journal-title":"Neurology"},{"key":"10.1007\/s13311-013-0230-5_bib71","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1212\/01.wnl.0000218297.90054.28","article-title":"No benefit of 3,4-diaminopyridine in essential tremor: a placebo-controlled crossover study","volume":"66","author":"Lorenz","year":"2006","journal-title":"Neurology"},{"key":"10.1007\/s13311-013-0230-5_bib72","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/mds.22872","article-title":"Carisbamate in essential tremor: brief report of a proof of concept study","volume":"25","author":"Elble","year":"2010","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0230-5_bib73","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/mds.870060310","article-title":"A double-blind trial of isoniazid for essential tremor and other action tremors","volume":"6","author":"Hallett","year":"1991","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0230-5_bib74","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/mds.21321","article-title":"Treatment of essential tremor with the barbiturate T2000 (1,3-dimethoxymethyl-5,5-diphenyl-barbituric acid)","volume":"22","author":"Melmed","year":"2007","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0230-5_bib75","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/mds.870110306","article-title":"A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor","volume":"11","author":"Jankovic","year":"1996","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0230-5_bib76","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1212\/WNL.56.11.1523","article-title":"A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor","volume":"56","author":"Brin","year":"2001","journal-title":"Neurology"},{"key":"10.1007\/s13311-013-0230-5_bib77","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000107360","article-title":"Intracerebral microvascular measurements during deep brain stimulation implantation using laser Doppler perfusion monitoring","volume":"85","author":"Wardell","year":"2007","journal-title":"Stereotact Funct Neurosurg"},{"key":"10.1007\/s13311-013-0230-5_bib78","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3171\/JNS\/2008\/109\/10\/0640","article-title":"Factors involved in long-term efficacy of deep brain stimulation of the thalamus for essential tremor","volume":"109","author":"Pilitsis","year":"2008","journal-title":"J Neurosurg"},{"key":"10.1007\/s13311-013-0230-5_bib79","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3171\/jns.2006.104.4.506","article-title":"Long-term evaluation of deep brain stimulation of the thalamus","volume":"104","author":"Pahwa","year":"2006","journal-title":"J Neurosurg"},{"key":"10.1007\/s13311-013-0230-5_bib80","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3171\/2009.10.JNS09371","article-title":"Long-term results of thalamic deep brain stimulation for essential tremor","volume":"112","author":"Zhang","year":"2010","journal-title":"J Neurosurg"},{"key":"10.1007\/s13311-013-0230-5_bib81","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/mds.1089","article-title":"Long-term safety and efficacy of unilateral deep brain stimulation of the thalamus in essential tremor","volume":"16","author":"Koller","year":"2001","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0230-5_bib82","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1212\/01.WNL.0000096012.07360.1C","article-title":"Long-term follow-up of thalamic deep brain stimulation for essential and parkinsonian tremor","volume":"61","author":"Kumar","year":"2003","journal-title":"Neurology"},{"key":"10.1007\/s13311-013-0230-5_bib83","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/mds.21481","article-title":"Thirty days complication rate following surgery performed for deep-brain-stimulation","volume":"22","author":"Voges","year":"2007","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0230-5_bib84","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1001\/archneurol.2010.69","article-title":"Gamma knife thalamotomy for disabling tremor: a blinded evaluation","volume":"67","author":"Lim","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1007\/s13311-013-0230-5_bib85","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3171\/JNS\/2008\/108\/01\/0111","article-title":"Gamma knife thalamotomy for essential tremor","volume":"108","author":"Kondziolka","year":"2008","journal-title":"J Neurosurg"},{"key":"10.1007\/s13311-013-0230-5_bib86","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.3171\/2009.10.JNS09332","article-title":"Gamma knife thalamotomy for treatment of essential tremor: long-term results","volume":"112","author":"Young","year":"2010","journal-title":"J Neurosurg"},{"key":"10.1007\/s13311-013-0230-5_bib87","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1212\/WNL.56.4.455","article-title":"A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease","volume":"56","author":"Shoulson","year":"2001","journal-title":"Neurology"},{"key":"10.1007\/s13311-013-0230-5_bib88","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S1474-4422(13)70048-6","article-title":"MR-guided focused ultrasound thalamotomy for essential tremor: a proof-of-concept study","volume":"12","author":"Lipsman","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-013-0230-5_bib89","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa1300962","article-title":"A pilot study of focused ultrasound thalamotomy for essential tremor","volume":"369","author":"Elias","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1007\/s13311-013-0230-5_bib90","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.brs.2012.04.009","article-title":"Cerebellar rTMS stimulation may induce prolonged clinical benefits in essential tremor, and subjacent changes in functional connectivity: an open label trial","volume":"6","author":"Popa","year":"2013","journal-title":"Brain Stimul"},{"key":"10.1007\/s13311-013-0230-5_bib91","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/mds.23019","article-title":"Distinguishing SWEDDs patients with asymmetric resting tremor from Parkinson's disease: a clinical and electrophysiological study","volume":"25","author":"Schwingenschuh","year":"2010","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0230-5_bib92","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.parkreldis.2010.06.013","article-title":"Advances in primary writing tremor","volume":"16","author":"Hai","year":"2006","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1007\/s13311-013-0230-5_bib93","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/mds.20782","article-title":"No correlation between the clinical severity of autonomic symptoms (SCOPA-AUT) and electrophysiological test abnormalities in advanced Parkinson's disease","volume":"21","author":"Papapetropoulos","year":"2006","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0230-5_bib94","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1590\/S0004-282X2008000600005","article-title":"Head tremor in patients with cervical dystonia: different outcome?","volume":"66","author":"Godeiro-Junior","year":"2008","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1007\/s13311-013-0230-5_bib95","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/mds.870120516","article-title":"Quantitative assessment of botulinum toxin treatment in 43 patients with head tremor","volume":"12","author":"Wissel","year":"1997","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0230-5_bib96","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1212\/WNL.0b013e31827b1a54","article-title":"Temporal discrimination in patients with dystonia and tremor and patients with essential tremor","volume":"80","author":"Tinazzi","year":"2013","journal-title":"Neurology"},{"key":"10.1007\/s13311-013-0230-5_bib97","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1212\/WNL.45.4.822","article-title":"Botulinum toxin treatment of essential head tremor","volume":"45","author":"Pahwa","year":"1995","journal-title":"Neurology"},{"key":"10.1007\/s13311-013-0230-5_bib98","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1212\/WNL.54.12.2342","article-title":"Thalamic stimulation for the treatment of midline tremors in essential tremor patients","volume":"54","author":"Obwegeser","year":"2000","journal-title":"Neurology"},{"key":"10.1007\/s13311-013-0230-5_bib99","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/jnnp.66.3.289","article-title":"Multicentre European study of thalamic stimulation in parkinsonian and essential tremor","volume":"66","author":"Limousin","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1007\/s13311-013-0230-5_bib100","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jvoice.2009.08.003","article-title":"Interarytenoid muscle botox injection for treatment of adductor spasmodic dysphonia with vocal tremor","volume":"25","author":"Kendall","year":"2011","journal-title":"J Voice"},{"key":"10.1007\/s13311-013-0230-5_bib101","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1002\/lary.24073","article-title":"A new paradigm for the management of essential vocal tremor with botulinum toxin","volume":"123","author":"Gurey","year":"2013","journal-title":"Laryngoscope"},{"key":"10.1007\/s13311-013-0230-5_bib102","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1001\/archneur.1986.00520060048016","article-title":"The physiology of orthostatic tremor","volume":"43","author":"Thompson","year":"1986","journal-title":"Arch Neurol"},{"key":"10.1007\/s13311-013-0230-5_bib103","first-page":"13","article-title":"Orthostatic tremor: clinical aspects, pathophysiology and therapy","volume":"18","author":"Deuschl","year":"1987","journal-title":"EEG-EMG Zeitschrift fur Elektroenzephalographie, Elektromyographie und verwandte Gebiete"},{"key":"10.1007\/s13311-013-0230-5_bib104","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/B978-0-444-52014-2.00035-5","article-title":"Orthostatic tremor \u2013 a review","volume":"100","author":"Gerschlager","year":"2011","journal-title":"Handb Clin Neurol"},{"key":"10.1007\/s13311-013-0230-5_bib105","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/mds.20830","article-title":"Blinded placebo crossover study of gabapentin in primary orthostatic tremor","volume":"21","author":"Rodrigues","year":"2006","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0230-5_bib106","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/mds.870130513","article-title":"Effective treatment of orthostatic tremor with gabapentin","volume":"13","author":"Evidente","year":"1998","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0230-5_bib107","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/sj.ejhg.5201539","article-title":"Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease","volume":"14","author":"Di","year":"2006","journal-title":"Eur J Hum Genet"},{"key":"10.1007\/s13311-013-0230-5_bib108","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/mds.870060111","article-title":"Orthostatic tremor: an association with essential tremor","volume":"6","author":"FitzGerald","year":"1991","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0230-5_bib109","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/mus.880161117","article-title":"Orthostatic tremor: clinical and electrophysiologic characteristics","volume":"16","author":"McManis","year":"1993","journal-title":"Muscle Nerve"},{"key":"10.1007\/s13311-013-0230-5_bib110","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/mds.20392","article-title":"Gabapentin can improve postural stability and quality of life in primary orthostatic tremor","volume":"20","author":"Rodrigues","year":"2005","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0230-5_bib111","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1002\/mds.23881","article-title":"Levetiracetam in primary orthostatic tremor: A double-blind placebo-controlled crossover study","volume":"26","author":"Hellriegel","year":"2011","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0230-5_bib112","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/mds.20132","article-title":"Natural history and syndromic associations of orthostatic tremor: A review of 41 patients","volume":"19","author":"Gerschlager","year":"2004","journal-title":"Movement Disorders"},{"key":"10.1007\/s13311-013-0230-5_bib113","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1002\/mds.22271","article-title":"Deep brain stimulation of the ventral intermediate nucleus of the thalamus in medically refractory orthostatic tremor: Preliminary observations","volume":"23","author":"Espay","year":"2008","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0230-5_bib114","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1002\/mds.22001","article-title":"Successful thalamic deep brain stimulation for orthostatic tremor","volume":"23","author":"Guridi","year":"2008","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0230-5_bib115","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1093\/brain\/124.8.1576","article-title":"Stereotactic lesional surgery for the treatment of tremor in multiple sclerosis: a prospective case-controlled study","volume":"124","author":"Alusi","year":"2001","journal-title":"Brain"},{"key":"10.1007\/s13311-013-0230-5_bib116","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/WNL.39.8.1113","article-title":"Treatment of cerebellar tremors with carbamazepine: a controlled trial with long-term follow-up","volume":"39","author":"Sechi","year":"1989","journal-title":"Neurology"},{"key":"10.1007\/s13311-013-0230-5_bib117","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/WNF.0b013e3181f84a39","article-title":"Successful treatment of cerebellar ataxia and tremor in multiple sclerosis with topiramate: a case report","volume":"33","author":"Schroeder","year":"2010","journal-title":"Clin Neuropharmacol"},{"key":"10.1007\/s13311-013-0230-5_bib118","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/WNF.0b013e31826249bb","article-title":"The efficacy of primidone in reducing severe cerebellar tremors in patients with multiple sclerosis","volume":"35","author":"Naderi","year":"2012","journal-title":"Clin Neuropharmacol"},{"key":"10.1007\/s13311-013-0230-5_bib119","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1177\/1352458512461394","article-title":"Treatment with 4-aminopyridine improves upper limb tremor of a patient with multiple sclerosis: a video case report","volume":"19","author":"Schniepp","year":"2013","journal-title":"Mult Scler"},{"key":"10.1007\/s13311-013-0230-5_bib120","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1212\/WNL.0b013e31825dcdd9","article-title":"A double-blind, randomized, controlled study of botulinum toxin type A in MS-related tremor","volume":"79","author":"Van Der Walt","year":"2012","journal-title":"Neurology"},{"key":"10.1007\/s13311-013-0230-5_bib121","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/mds.22059","article-title":"Long-term follow-up of thalamic stimulation versus thalamotomy for tremor suppression","volume":"23","author":"Schuurman","year":"2008","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0230-5_bib122","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000177625","article-title":"Venous air embolism in deep brain stimulation","volume":"87","author":"Hooper","year":"2009","journal-title":"Stereotact Funct Neurosurg"},{"key":"10.1007\/s13311-013-0230-5_bib123","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/mds.24005","article-title":"Long-lasting effect of levodopa on holmes' tremor","volume":"27","author":"Boelmans","year":"2012","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0230-5_bib124","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000120429","article-title":"Ventral intermediate thalamic stimulation in complex tremor syndromes","volume":"86","author":"Diederich","year":"2008","journal-title":"Stereotact Funct Neurosurg"},{"key":"10.1007\/s13311-013-0230-5_bib125","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/1531-8257(200101)16:1<170::AID-MDS1033>3.0.CO;2-P","article-title":"Bilateral thalamic stimulation for Holmes' tremor caused by unilateral brainstem lesion","volume":"16","author":"Kudo","year":"2001","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0230-5_bib126","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.3171\/jns.2004.100.6.1079","article-title":"Deep brain stimulation of the nucleus ventralis intermedius for Holmes (rubral) tremor and associated dystonia caused by upper brainstem lesions. Report of two cases","volume":"100","author":"Nikkhah","year":"2004","journal-title":"J Neurosurg"},{"key":"10.1007\/s13311-013-0230-5_bib127","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000099072","article-title":"Multiple target deep brain stimulation for multiple sclerosis related and poststroke Holmes' tremor","volume":"85","author":"Lim","year":"2007","journal-title":"Stereotact Funct Neurosurg"},{"key":"10.1007\/s13311-013-0230-5_bib128","first-page":"E445","article-title":"Ventralis intermedius plus ventralis oralis anterior and posterior deep brain stimulation for posttraumatic Holmes tremor: two leads may be better than one: technical note","volume":"56","author":"Foote","year":"2005","journal-title":"Neurosurgery"},{"key":"10.1007\/s13311-013-0230-5_bib129","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1136\/jnnp-2012-303013","article-title":"Tremor in inflammatory neuropathies","volume":"84","author":"Saifee","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1007\/s13311-013-0230-5_bib130","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1001\/archneur.1984.04050180033012","article-title":"Tremor as a feature of chronic relapsing and dysgammaglobulinemic polyneuropathies. Incidence and management","volume":"41","author":"Dalakas","year":"1984","journal-title":"Arch Neurol"},{"key":"10.1007\/s13311-013-0230-5_bib131","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/brain\/119.3.789","article-title":"Tremor associated with benign IgM paraproteinaemic neuropathy","volume":"119","author":"Bain","year":"1996","journal-title":"Brain"},{"key":"10.1007\/s13311-013-0230-5_bib132","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/WNF.0b013e3181585b71","article-title":"Tremor associated with chronic inflammatory demyelinating peripheral neuropathy: treatment with pregabalin","volume":"31","author":"Alonso-Navarro","year":"2008","journal-title":"Clin Neuropharmacol"},{"key":"10.1007\/s13311-013-0230-5_bib133","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/mds.22961","article-title":"Pregabalin in the treatment of neuropathic tremor following a motor axonal form of Guillain-Barre syndrome","volume":"25","author":"Coltamai","year":"2010","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0230-5_bib134","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/mds.10510","article-title":"VIM thalamic stimulation for tremor in a patient with IgM paraproteinaemic demyelinating neuropathy","volume":"18","author":"Ruzicka","year":"2003","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0230-5_bib135","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/mds.23374","article-title":"Central oscillators in a patient with neuropathic tremor: evidence from intraoperative local field potential recordings","volume":"26","author":"Weiss","year":"2011","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0230-5_bib136","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/jnnp.2008.145656","article-title":"Effective thalamic deep brain stimulation for neuropathic tremor in a patient with severe demyelinating neuropathy","volume":"80","author":"Breit","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1007\/s13311-013-0230-5_bib137","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S1474-4422(08)70190-X","article-title":"Clinical applications of transcranial magnetic stimulation in patients with movement disorders","volume":"7","author":"Edwards","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-013-0230-5_bib138","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/WCO.0b013e32832dc169","article-title":"Psychogenic movement disorders","volume":"22","author":"Gupta","year":"2009","journal-title":"Curr Opin Neurol"},{"key":"10.1007\/s13311-013-0230-5_bib139","doi-asserted-by":"crossref","DOI":"10.1136\/practneurol-2013-000549","article-title":"How to use the entrainment test in the diagnosis of functional tremor","author":"Roper","year":"2013","journal-title":"Pract Neurol"},{"key":"10.1007\/s13311-013-0230-5_bib140","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S1474-4422(11)70310-6","article-title":"Functional (psychogenic) movement disorders: merging mind and brain","volume":"11","author":"Edwards","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-013-0230-5_bib141","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/mds.22952","article-title":"The effects of physical activity on psychogenic movement disorders","volume":"25","author":"Dallocchio","year":"2010","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0230-5_bib142","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.4088\/JCP.v66n1206","article-title":"Antidepressant treatment outcomes of psychogenic movement disorder","volume":"66","author":"Voon","year":"2005","journal-title":"J Clin Psychiatry"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-013-0230-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13311-013-0230-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923016434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923016434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-013-0230-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:08:17Z","timestamp":1761808097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923016434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":142,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S1878747923016434"],"URL":"https:\/\/doi.org\/10.1007\/s13311-013-0230-5","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Treatment of Tremor","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-013-0230-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}